Skip to content
EU comission subsidy program
Neofar IKE Company Logo
  • Home
  • About Us
    • Company Profile
    • Partners
    • Indicative Publications
      • Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis
      • Cyclic citrullinated MBP87–99 peptide stimulates T cell responses: Implications in triggering disease
      • Cyclic MOG35–55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis
  • Fields to be Explored
    • Hypertension
    • Multiple Sclerosis
  • Services
  • Contact
  • ΕΛΛ
Menu Close
  • Home
  • About Us
    • Company Profile
    • Partners
    • Indicative Publications
      • Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis
      • Cyclic citrullinated MBP87–99 peptide stimulates T cell responses: Implications in triggering disease
      • Cyclic MOG35–55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis
  • Fields to be Explored
    • Hypertension
    • Multiple Sclerosis
  • Services
  • Contact
  • ΕΛΛ

Indicative Publications

The present experimental study indicates a reduced encephalitogenic effect of cPLP peptide compared to its linear analog.

Our clinical and histopathological data of acute phase….

…(Click to Read More)

The present experimental study indicates a reduced encephalitogenic effect of cPLP peptide compared to its linear analog.

Our clinical and histopathological data of acute phase (highest disease activity) converge….

…(Click to Read More)

The immunogenicity of linear-Cit and cyclic-Cit peptides in mice is a first report, which gives insights into the triggers of the disease.

Cyclic-Cit peptide conjugated to reduced mannan induced strong IFN-c and IL-4 cytokine….

…(Click to Read More)

Copyright NEOFAR | NewDrug IKE 2021 - OWP Powered by kataskevi-Eshop.EU